Pediatric vaccine market to reach $107.8 billion by 2030 at 13.5% cagr, driven by rising prevalence of pediatric diseases.
Read MorePediatric supplements market to reach $5.76 billion by 2030 at 6.5% cagr, driven by growing prevalence of nutritional deficiencies.
Read MoreThe global pediatric drugs market to reach $352.69 billion by 2030 at 14.4% cagr, driven by growing number of preterm births.
Read MorePediatric asthma treatment market to reach $15.14 billion by 2030 at 5.3% cagr, driven by increasing prevalence of respiratory infections.
Read MorePeanut allergy treatment market to reach $0.8 billion by 2030 at 9.7% cagr, driven by investment in research and development of allergy treatments.
Read MorePeanut allergy treatment market to reach $0.8 billion by 2030 at 9.7% cagr, driven by investment in research and development of allergy treatments.
Read MoreMrna therapeutics cdmo market to reach $8.26 billion by 2030 at 11.7% CAGR, driven by growing burden of chronic and infectious diseases.
Read MoreMrna therapeutics market to reach $42.32 billion by 2030 at 3.3% CAGR, driven by increasing prevalence of long-lasting and communicable diseases.
Read MoreMrna cancer vaccines and therapeutics market to reach $141.51 billion by 2030 at 14.4% CAGR, driven by rising prevalence of cancer.
Read MoreMorphine drugs market to reach $30.17 billion by 2030 at 5.3% CAGR, driven by increasing prevalence of chronic pain conditions.
Read More